Glaucoma Surgery Devices Market Report 2026

Glaucoma Surgery Devices Market Overview

• Glaucoma Surgery Devices market size has reached to $2.13 billion in 2025 • Expected to grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 14.6% • Growth Driver: Rising Prevalence Of Glaucoma To Propel Growth Of The Glaucoma Surgery Devices Market • Market Trend: Innovative Laser Technology Offers Precise, Non-Invasive Treatment For Glaucoma • North America was the largest region in 2025.

What Is Covered Under Glaucoma Surgery Devices Market?

Glaucoma surgery devices refer to various medical instruments and tools used to perform surgical procedures on the eye to treat glaucoma. The goal of surgical glaucoma treatment is to increase aqueous outflow capacity to decrease intraocular pressure. Glaucoma is a group of eye diseases that damage the optic nerve and can result in vision loss and blindness. The main types of glaucoma surgery devices are drainage systems, laser-based devices, implants, and others, which are used to treat open-angle and closed-angle glaucoma. Drainage systems refer to catheters positioned close to the surgical site to drain any blood, pus, or fluid and stop it from building up inside the body. Various types of surgery are included, such as angle closure glaucoma surgery, aqueous shunt surgery, laser surgery, and others. Drainage systems refer to catheters positioned close to the surgical site to drain any blood, pus, or fluid and stop it from building up inside the body. These are used for several applications, such as conventional glaucoma surgeries and minimally invasive glaucoma surgeries, and are used by various end users, such as eye hospitals, ophthalmology clinics, and outpatient surgical centers.

What Is The Glaucoma Surgery Devices Market Growth Forecast?

The glaucoma surgery devices market size is expected to see rapid growth in the next few years. It will grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing aging population, rising adoption of MIGS procedures, growing investments in ophthalmic innovation, increasing demand for outpatient eye surgeries, expansion of advanced glaucoma treatment access. Major trends in the forecast period include increasing adoption of minimally invasive glaucoma surgery devices, rising use of micro-invasive glaucoma implants, growing integration of laser-based treatment systems, expansion of personalized glaucoma treatment approaches, enhanced focus on surgical precision and safety.

Global Glaucoma Surgery Devices Market Segmentation

1) By Product: Drainage Systems, Laser-Based Devices, Implants 2) By Treatment: Open-Angle, Closed-Angle 3) By Type Of Surgery: Angle Closure Glaucoma Surgery, Aqueous Shunt Surgery, Laser Surgery 4) By Application: Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries 5) By End User: Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers Subsegments: 1) By Drainage Systems: Tubes And Shunts, Valves 2) By Laser-Based Devices: Laser Trabeculoplasty, Laser Iridotomy Devices, Laser Cyclophotocoagulation Devices 3) By Implants: Gel Stents, Ahmed Glaucoma Valve Implants, Baerveldt Implants

What Is The Driver Of The Glaucoma Surgery Devices Market?

The growth in the prevalence of glaucoma is expected to boost the growth of the glaucoma surgery devices market. Glaucoma is a progressive eye disease that damages the optic nerve and can lead to permanent vision loss if not diagnosed and treated promptly. Glaucoma surgery devices play a major role in executing glaucoma surgery, and they have made glaucoma surgeries safer, more effective, and less invasive, which significantly contributes to the increasing demand. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2025, over 3 million Americans are affected by glaucoma, and this number is projected to increase to 6.3 million by 2050 due to the aging population in the US. Therefore, the growth in the prevalence of glaucoma will drive the glaucoma surgery devices industry forward.

Key Players In The Global Glaucoma Surgery Devices Market

Major companies operating in the glaucoma surgery devices market are Alcon, Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb, Glaukos Corporation, Sight Sciences, Iridex Corporation, Ellex Medical Lasers, Lumenis, Ziemer Ophthalmic Systems, Nidek, Topcon, BVI, Rheon Medical, New World Medical, Haag-Streit, OptoLight Vision Technology, Katalyst Surgical, Aerie Pharmaceuticals, MicroSurgical Technology, iSTAR Medical

Global Glaucoma Surgery Devices Market Trends and Insights

Major companies operating in the glaucoma surgery devices market are focusing on developing innovative solutions, such as direct selective laser trabeculoplasty (DSLT) devices, to provide precise, non-invasive treatment for lowering intraocular pressure in glaucoma patients. Direct selective laser trabeculoplasty (DSLT) devices are advanced ophthalmic tools that use targeted laser energy to treat the eye’s drainage system, reducing intraocular pressure in glaucoma patients without invasive surgery. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care device company, launched Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty (DSLT) device for treating glaucoma and ocular hypertension. Voyager DSLT is a fully automated system that delivers 120 laser pulses precisely to the trabecular meshwork via the limbus using advanced eye-tracking technology, without requiring a gonio lens or manual aiming. This innovation enhances aqueous outflow to lower intraocular pressure, simplifying the procedure for physicians while improving patient comfort. By enabling a fast, non-contact, and comfortable treatment, the device is suitable as a first-line therapy, potentially reducing patients’ reliance on medications while maintaining a strong safety profile.

What Are Latest Mergers And Acquisitions In The Glaucoma Surgery Devices Market?

In July 2024, Alcon Inc., a Switzerland-based eye care device company acquired Belkin Vision for an undisclosed amount. With this acquisition, Alcon aims to expand its glaucoma surgery devices portfolio by integrating Belkin Vision’s Direct Selective Laser Trabeculoplasty (DSLT) platform, strengthening its capabilities in non-incisional glaucoma intervention and enhancing its presence across the glaucoma treatment continuum. Belkin Vision Ltd is a Israel-based medical device company that provides glaucoma surgery devices

Regional Outlook

North America was the largest region in the glaucoma surgery devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Glaucoma Surgery Devices Market?

The glaucoma surgery devices market consists of sales of ultrasound equipment, tube shunts, and aqueous shunts that help to perform glaucoma surgeries. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.